This aligns with reports that AHR antagonists (6,2,4′-trimethoxyflavone) protect against ischemic stroke by blocking microglial activation and preserving neurogenesis (130, 136), while indoxyl sulfate promotes neurotoxic environments in glial co-cultures. The gene discussed is AHR; the disease is ischemic stroke.